Physician

Anesthesiology

Dr. Takeshi Kishida practices Anesthesiology. He went to Osaka University Medical School. Takeshi Kishida has written publications. He has 101 publications published with PubMed. The lastest paper is: 'The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients.' Doctor Takeshi Kishida, MD is registered with Medicare.

Publications

---

• [Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia].
• CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
• [Case of lymphangiomyomatosis of the kidney and retroperitoneum].
• Clinical significance of low level human chorionic gonadotropin in the management of testicular germ cell tumor.
• A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.
• Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy.
• Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on surv...
• [Clinical study of penis-conserving treatment for carcinoma of penis].
• Evaluation of response to multikinase inhibitor in metastatic renal cell carcinoma by FDG PET/contrast-enhanced CT.
• Copy number profiling in von Hippel-Lindau disease renal cell carcinoma.
• Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
• Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
• Computerized tomography nephroscopic images of renal pelvic carcinoma.
• [Prognostic factors for metastatic renal cell cancer].
• Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
• [Prognosis in the cases with renal cell carcinoma according to clinical parameters].
• Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/peptide transporter PEPT2 me...
• Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
• Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.
• Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth.
• Retinoblastoma gene mutation in primary human renal cell carcinoma.
• Sporadic bilateral papillary renal carcinoma exhibiting C-met mutation in the left kidney tumor.
• The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients.
• Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.
• Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
• PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.
• [Molecular genetic mechanism of the kidney cancer].
• Direct interaction of the beta-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes.
• Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.
• Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
• Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations.
• Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
• Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
• [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin''s lymphoma].
• Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma.
• [Prostate cancer: retrospective study of long-term follow-up cases. Is it possible to discontinue hormonal medications?].
• An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association.
• [Treatment of acute leukemia with "MB-triple V" therapy--a comparative study of "MB-triple V" therapy and B-triple V therapy].
• [Timing of administration of granulocyte colony stimulating factor after cytotoxic chemotherapy in hematological malignancies].
• Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
• A novel donor splice site mutation associated with two mRNAs in von Hippel-Lindau disease.
• Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.
• SPARC expression in primary human renal cell carcinoma: upregulation of SPARC in sarcomatoid renal carcinoma.
• Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.
• Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
• Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer.
• Expression of von Hippel-Lindau protein in normal and pathological human tissues.
• Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans.
• [Two cases of mucinous adenocarcinoma of the prostate].
• Detection of germline mutations in the von Hippel-Lindau disease gene by the primer specified restriction map modification method.
• Induction of cyclooxygenase-2 in mesothelial cells in peritonitis caused by perforated ulcers--an immunohistochemical study in humans.
• Endoscopic diagnosis of lower intestinal lesions of leukaemia and malignant lymphoma.
• Differential interleukin 12 responsiveness for interferon gamma production in advanced stages of cancer patients correlates with performance status.
• SLIT2 promoter methylation analysis in neuroblastoma, Wilms'' tumour and renal cell carcinoma.
• Activating mutations for the met tyrosine kinase receptor in human cancer.
• Evaluation of 117 patients with non-Hodgkin''s lymphoma in the past ten years at our department.
• [Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
• Tumor degeneration by human embryonic fibroblasts and its enhancement by interferon.
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
• [Peripheral blood stem cell transplants: clinical considerations and observations in practice in a general hospital].
• [Interferon-producing capacity in patients with prostate cancer: prognosis value].
• [Interferon-alpha producing capacities in prostatic cancer patients].
• Clinical significance of serum iron and ferritin in patients with colorectal cancer.
• Influence of alcohol consumption on the association between serum lipids and colorectal adenomas.
• Risk of colorectal cancer in patients with hematologic disease.
• Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.
• Superficial blood flow, blood volume, and blood velocity in colorectal tubular adenomas and adenocarcinomas.
• Mean corpuscular volume may be a useful index of risk for colorectal adenoma in middle-aged Japanese men.
• Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
• Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects.
• Comparison of an improved AFP kit with the intra-amniotic PSP dye-injection method in equivocal cases of preterm premature rupture of the fetal membranes.
• Significance of serum iron and ferritin in patients with colorectal adenomas.
• [Factor VIII inhibitor found in a patient with Sjögren's syndrome].
• Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.
• An endoscopic study of antibiotic-associated hemorrhagic colitis.
• [Progress of electronic endoscopic diagnosis of polyps].
• Abustracts from japanese journal of hygiene (Nihon Eiseigaku Zasshi) Vol.54 No.4.
• [Adult T-cell leukemia/lymphoma with OKT4 lack of OKT8 in peripheral blood and with OKT4 and OKT8 in lymph node. Study of two color flow cytometry].
• Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo.
• INHIBITORY EFFECT OF INTERFERON ON THE MULTIPLICATION OF SHOPE FIBROMA VIRUS IN VITRO.
• [Virus-associated hemophagocytic syndrome due to EB virus].
• [Differentiating effect of the oral administration of vitamin D and vitamin A in acute myelocytic leukemia after BHAC-DMP therapy].
• Evaluation of bone marrow involvement of malignant lymphoma by bone marrow aspiration and biopsy: necessity to evaluate both samples together.
• [Effect of the inhibitor factor of the virus on the intracellular inclusion produced by the Shope fibroma virus].
• [A case report on tooth erosions apparently caused by excessive eating of citrus fruits].
• Autoradiographic studies on intracytoplasmic multiplication of Toxoplasma gondii in FL cells.
• [Two color flow cytometry of lymphocytes from patients with adult T-cell leukemia].
• [Juvenile Crow-Fukase syndrome with response to bolus of methylprednisolone after failure of treatment by plasma exchange].
• Clinical study of malignant lymphoma of head and neck in the nasal cavity and Waldyer''s ring.
• [Sweet''s syndrome associated with myelodysplastic syndrome].
• [Clinical evaluation of panipenem/betamipron in severe infections complicating hematological disorders].
• Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
• [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
• [Cyclosporin therapy for idiopathic thrombocytopenic purpura].
• Therapy with mitoxantrone, ifosfamide, vindesine, and prednisolone for malignant lymphoma with adjustable doses and timing of courses.
• Evaluation of serum sialyl Lewisx-i in hematologic disorders.
• Increased frequency of HLA-DR4 allele in women with unexplained recurrent spontaneous abortions, detected by the method of PCR-SSP.
• Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients.
• [Expression of pre-S1 antigen and pre-S1 antibody in sera obtained from HBV infected patients].
• [Hepatic functional reserve capacity and hepatic blood flow, hepatic oxygen consumption and glucose tolerance (author''s transl)].

Doctors Specialties

---

• Anesthesiology

Accepted Insurances

---

• Choice Plus POS II
• Blue Card PPO
• Cigna PPO
• Open Access Plus
• Humana
• Medicare MCR
• National Elevator

Education

---

• Henry Ford Hospital - Wayne State University
• Osaka University Medical School

Drug Facts

---

NPI NUMBER		1114006111
NPPES Provider LastName		KISHIDA
NPPES Provider FirstName		TAKESHI
NPPES Provider ZIPCode		968172532
NPPES Provider State		HI
Specialty Description		Anesthesiology
Total Claim Count		14.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1114006111
Last Name Of The Provider	KISHIDA
First Name Of The Provider	TAKESHI
View All

Similar Doctors

---

	Dr. Albert T. Honda, MD This Doctor is OpenDoctor Recommended.
	Dr. Della M. Lin, MD This Doctor is OpenDoctor Recommended.
	Dr. Lilian Y. Kanai, MD This Doctor is OpenDoctor Recommended.
	Dr. Pamela E. Nunn, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian Garcia, MD This Doctor is OpenDoctor Recommended.
	Dr. Brandi N. Blair, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward R. Campbell, MD
	Dr. Roland F. Tam, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew W. Maeda, MD
	Dr. Dan S. Yoshioka, MD This Doctor is OpenDoctor Recommended.
	Dr. Frank D. Chang, MD
	Dr. Efren D. Baria, MD This Doctor is OpenDoctor Recommended.
	Dr. Jonn I. Saruwatari, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel J. Clark, DO

---

Doctor Directory | TOS | twitter | FB | Angel | blog